CRISPR Therapeutics AG

CRSP· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$49.57+3.29%

2026-08-03

Financials

Valuation Metrics

CRISPR Therapeutics AG's Market Cap is $4.78B. At end of 2025 it was $4.72B. Ranked #1429 of 3,112 in US market (top 46%), #494 of 1,445 on NASDAQ (top 34%), #80 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 30%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$4.78B	US#1,429/3,112 Sec#80/269
Revenue	$4M	US#2,943/3,112 Sec#190/269
Net Income	$-569M	US—/3,112 Sec—/269
Total Assets	$2.73B	US#1,868/3,112 Sec#45/269
Net Assets	$1.81B	US#1,322/3,112 Sec#41/269
Value
P/B	2.63x	US#1,526/3,112 Sec#75/269
P/S	1362.10x	US#2,953/3,112 Sec#199/269
FCF Yield	-8.39%	US—/3,112 Sec—/269
Profitability
ROE	-31.33%	US#2,626/3,112 Sec#129/269
ROA	-20.86%	US#2,785/3,112 Sec#127/269
Op. Margin	-13408.29%	US#2,960/3,112 Sec#197/269
Revenue Growth	68.55%	US#216/3,112 Sec#44/269
Financial Health
Debt Ratio	50.22%	US#575/3,112 Sec#138/269
Total Debt	$788M	US#1,595/3,112 Sec#49/269
FCF	$-401M	US#2,812/3,112 Sec#250/269
Cash	$423M	US#1,187/3,112 Sec#66/269
Current Ratio	17.96x	US#140/3,112 Sec#39/269
Performance
1Y Return	-11.62%	US#2,511/3,112 Sec#218/269
1M Return	-17.49%	US#2,892/3,112 Sec#224/269
From 52W High	-36.84%	US#2,426/3,112 Sec#185/269
1Y MDD	-42.25%	US#2,060/3,112 Sec#152/269
Trading
Volume	1,363,788 shares	US#1,203/3,112 Sec#116/269
Trading Value	$67M	US#1,164/3,112 Sec#68/269
Per Share
EPS	$-6.47	US—/3,112 Sec—/269
BPS	$21.37	US#1,139/3,112 Sec#28/269